Davita-Brimhall Dialysis is a medicare approved dialysis facility center in Bakersfield, California and it has 20 dialysis stations. It is located in Kern county at 8501 Brimhall Road, Bldg. 500, Bakersfield, CA, 93312. You can reach out to the office of Davita-Brimhall Dialysis at (661) 387-6603. This dialysis clinic is managed and/or owned by Davita. Davita-Brimhall Dialysis has the following ownership type - Profit. It was first certified by medicare in November, 1985. The medicare id for this facility is 052635 and it accepts patients under medicare ESRD program.
| Name | Davita-Brimhall Dialysis |
|---|---|
| Location | 8501 Brimhall Road, Bldg. 500, Bakersfield, California |
| No. of Dialysis Stations | 20 |
| Medicare ID | 052635 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 8501 Brimhall Road, Bldg. 500, Bakersfield, California, 93312 | |
| (661) 387-6603 | |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
| NPI Number | 1629042148 |
| Organization Name | Bakersfield Brimhall Dialysis |
| Doing Business As | Dva Healthcare Renal Care Inc |
| Address | 8501 Brimhall Rd Bakersfield, California, 93312 |
| Phone Number | (661) 322-4911 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 60% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 11% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 29% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 57% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 14% |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 61% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 20% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 19% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 12% |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 82% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 18% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 67% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 6% | 12% |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 65 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 140 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1185 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Brimhall Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 144 |
| Hypercalcemia patient months | 1237 |
| Patients with Serumphosphor | 154 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 19 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 115 |
| Patient months included in arterial venous fistula and catheter summaries | 827 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 106 |
| Hospitalization Rate in facility | 174.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 293.2 |
| Hospitalization Rate: Lower Confidence Limit | 112.2 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita-Brimhall Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 33.8 |
| Readmission Rate: Lower Confidence Limit | 17.8 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita-Brimhall Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.83 (Worse than Expected) |
| SIR: Upper Confidence Limit | 2.94 |
| SIR: Lower Confidence Limit | 1.06 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita-Brimhall Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 97 |
| Transfusion Rate in facility | 56.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 104.8 |
| Transfusion Rate: Lower Confidence Limit | 32.5 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita-Brimhall Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 610 |
| Mortality Rate in facility | 21.9 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 27.2 |
| Mortality Rate: Lower Confidence Limit | 17.4 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago
Davita-Brimhall Dialysis Location: 8501 Brimhall Road, Bldg. 500, Bakersfield, California, 93312 Phone: (661) 387-6603 |
Davita-Bakersfield Dialysis Center Location: 5143 Office Park Drive, Bakersfield, California, 93309 Phone: (661) 325-4741 |
Davita-Northeast Bakersfield Dialysis Location: 3761 Mall View Road, Bakersfield, California, 93306 Phone: (661) 872-9836 |
Davita-White Lane Dialysis Location: 7701 White Lane, Suite D, Bakersfield, California, 93309 Phone: (661) 396-7158 |
Fmc-Bakersfield Location: 8625 Liberty Park Drive, Suite 102, Bakersfield, California, 93311 Phone: (661) 664-0158 |
News Archive
It is not unusual to hear people blame their metabolism after gaining a few pounds. But changes in metabolism - the process that shapes how our bodies turn food into energy - can have much more sinister effects than making it hard to fit into your favorite jeans.
Harmful gender, religious and cultural norms contribute to risky pregnancies in older women and women who already have five or more children, endangering the lives of these women and their babies, suggests new research from the Johns Hopkins Center for Communication Programs.
Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
› Verified 2 days ago